Stage IIIC Prostate Cancer AJCC v8 Recruiting Phase 4 Trials for Relugolix (DB11853)

IndicationStatusPhase
DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs